Friday, 28 April 2017

Global Pulmonary Arterial Hypertension Market By Geography Products Analyzers 2014 - 2020

The global pulmonary arterial hypertension (PAH) market is progressing at a high CAGR of 17.90% within a forecast period of 2014 to 2020. This market was recorded at US$4.04 bn in 2013, and is expected to reach US$5.19 bn by the end of 2020. The data is presented in a unique and comprehensive manner in a research report released by Transparency Market Research, titled “Pulmonary Arterial Hypertension (PAH) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.” 


Pulmonary arterial hypertension is when the blood pressure inside the small arteries within the lungs increases. PAH can cause swelling of legs, fainting, dizziness, and shortness of breath, among other more serious symptoms. One of the biggest problems that a patient with PAH suffers is an extremely low tolerance to exercise. PAH can escalate into pulmonary vascular resistance and cause the failure of the right ventricle.

According to the report, the primary driver for the global PAH market is the list of newly-approved drugs and medical products aimed at treating PAH. A large number of medical products are already approved, while more are still in the pipeline. Another factor promoting the growth of the global PAH market is the increasing number of leaps taken in research and development efforts, aided by government policies and other initiatives.

The report provides a segmented analysis of the global PAH market. These segments are sorted within the categories of drug class and geography. The report also provides an extensive analysis of the pipeline drugs in the global PAH market.

In terms of drug class, the global PAH market is segmented into soluble guanylate cyclase (sGC) stimulators, phosphodiesterase-5 (PDE-5) inhibitors, endothelin receptor antagonists (ERAs), and prostacyclin and prostacyclin analogs. Of these, the report’s authors have put the prostacyclin and prostacyclin analogs segment ahead of the ERA segment, which means that the segment will lead the global PAH market by 2023, surpassing the current leader, ERAs.

The report’s geographical segmentation of the global PAH market reveals Asia Pacific to be the fastest-growing region for the given forecast period. The growth rate of this region is attributed to major opportunities that will be found in Australia, New Zealand, Japan, China, and India. Enterprises operating in these regions could take advantage of these opportunities and increase their profits and presence in the market.

The report, however, states one of the major restraints on the global PAH market as the challenges faced by the Rest of the World PAH market. The report’s study shows that most of the nations in the Rest of the World region possess a low level of awareness of this market’s products. Therefore, this region is showing a much slower growth rate when compared to the regions of North America or Europe.

The key players in the global pulmonary arterial hypertension market are United Therapeutics Corp., Novartis International AG, Pfizer Inc., GlaxoSmithKline plc, Bayer HealthCare, Gilead Sciences Inc., and Actelion Pharmaceuticals Ltd.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1181

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Outlook for Hyperbaric Oxygen Therapy Devices Market By Key Trends and Analysis 2020

HBOT is a technique of delivering pure oxygen (100%) to the tissues under higher atmospheric pressures. Due to its ability to enhance the activities of the white blood cells at the wound site and block the cytotoxic effects of cyanide and carbon monoxide, HBOT is gaining wide acceptance across the globe. It has been studied that HBOT saturates the circulatory system of a patient with oxygen, which results in augmented oxygen delivery to the tissues that produce therapeutic effect in a patient’s body. HBOT is used for various medical indications such as necrotizing soft tissue infections, thermal burn injury, decompression sickness, etc. for which they have an FDA approval, however it has been observed that apart from the approved medical conditions HBOT is also used as a viable treatment for many off-label indications such as brain injuries and cancer. Thus, due to the high preference of hyperbaric oxygen therapy among physicians and patients the market of HBOT devices is expected to grow significantly in the near future, across the regions.


Within product segment that includes monoplace hyperbaric oxygen therapy devices, multiplace hyperbaric oxygen therapy devices and topical HBOT devices; monoplace devices emerged as the market leader in terms of revenue in 2013. The substantiating factors behind such strong growth of the monoplace chambers market are wide commercial availability, low-space requirement and easy installation procedures. Moreover, the monoplace HBOT devices market is expected to exhibit highest growth rate due to the rapid growth in demand owing to their portable design, easy operability of these chambers and low maintenance cost. The trend is expected to continue due to the increasing incidence of chronic wounds across the world.

Within the application segment, wound healing accounted for the largest market share of over 60% of the total hyperbaric oxygen therapy devices market. Moreover, due to the positive outcomes of clinical studies that were investigating the effects of HBOT in patients with diabetic foot ulcers coupled with high incidence rate of acute and chronic wounds are expected to substantiate the leading growth of wound healing segment in the overall hyperbaric oxygen therapy devices market.

North America was the largest market for hyperbaric oxygen therapy devices in terms of revenue in 2013, followed by Europe. The contributing factor behind the dominance of North America are existence of large number of hyperbaric oxygen therapy providers, high preference for portable hyperbaric chambers among physicians, coupled with growing prevalence of  chronic wounds in the general population. Moreover, perpetual product innovation policies and custom-made devices procurement procedures have driven the practice of hyperbaric oxygen therapy devices in the U.S., thereby making North America the market leader for hyperbaric oxygen therapy devices. Alternatively, in terms of growth rate, Asia Pacific is expected to witness the highest growth due to the alarmingly rising incidence of diabetes and diabetes associated chronic wounds among population coupled with exponentially growing healthcare facilities in nations such as China, Malaysia, India and Singapore; that would contribute to the high growth of hyperbaric oxygen therapy devices market in the region.

The global hyperbaric oxygen therapy devices market is highly competitive and oligopolistic at nature. Sechrist Industries, Inc., OxyHeal Health Group, ETC Biomedical System, IHC Hytech B.V. and SOS Medical Group Ltd. exhibit the widest geographical reach coupled with a wide range of hyperbaric oxygen devices and addressing to a large base of consumers across the globe. Their existence in developed and emerging nations along with vivid product offerings has made them successful providers of hyperbaric oxygen therapy devices or chambers in the global market. Other companies considered for this study are Fink Engineering Pty Ltd., Haux-Life-Support GmbH, Gulf Coast Hyperbaric, Inc., Hearmec Co., Ltd. and Hyperbaric SAC, etc.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=806

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Artificial Pancreas Device Systems Market By Geography Products Analyzers 2016 - 2024

Pancreas is a vital organ of the body, particularly the digestive system. It is a flat gland of about 6 inches, which is located in the abdomen and is surrounded by stomach, small intestine, liver, spleen, and gall bladder. It secrets several crucial hormones such as insulin and glucagon as well as enzymes for digestion and other metabolic processes in the body. Insulin lowers the blood sugar level of the body by enabling the cells to take up sugar in the form of glucose from the blood to produce energy. Glucagon helps in raising the blood sugar level by making the liver release stored glucose. The imbalance or improper functioning of these two hormones may lead to imbalance of the blood sugar level leading to diabetes.

Diabetes can be of four types: type I diabetes, type II diabetes, prediabetes, and gestational diabetes. In type I diabetes, no insulin is produced by the body. This accounts for approximately 10% of the total diabetes cases. In type II diabetes, insulin produced is insufficient to balance the blood sugar level. Prediabetes is a condition wherein the blood sugar level is high but is not sufficient to be called diabetes. In gestational diabetes, the blood sugar level is high in pregnant women.


The artificial pancreas device system, also referred to as closed-loop system, automated insulin delivery system, or autonomous system for glycemic control, is basically a system of devices coupled together to imitate the glucose regulation by a healthy pancreas. Artificial pancreas device system primarily consists of a continuous glucose monitoring (CGM) system, an insulin infusion pump, and a controlled algorithm. The CGM system constantly provides information about the patient’s blood glucose level. This is achieved by placing a sensor under the patient’s skin, which measures the glucose level in the interstitial fluid (fluid around cells). Thereby, both an evaluation of blood glucose level and their direction and rate of change of these evaluations are shown. Controlled algorithm is a software that can be installed on any device such as computer or cellular phone. It establishes constant communication between the CGM and the insulin pump. It collects the information from CGM and calculates it. On the basis of this information, the algorithm directs the insulin pump about the doses. The insulin infusion pump delivers insulin to the tissue under the skin in adequate doses as per the information received from the controlled algorithm.

Diabetes is a metabolic disorder. Unhealthy lifestyle, increasing trend of eating junk food and fast food, and lack of exercise are some of the factors leading to diabetes. These are also the factors driving the market for artificial pancreas device systems. Personal monitoring of insulin levels has shown improvement in the health of patients suffering from diabetes. Use of modern technologies, digitalization, and wireless and portable devices is likely to propel the artificial pancreas device systems market. However, constant maintenance and calibration of the glucose monitor, alteration in the efficiency of sensors caused by fibrosis (as sensors are placed subcutaneously) and the quality of insulin are some of the factors likely to hamper the artificial pancreas device systems market.

The artificial pancreas device systems market can be segmented into threshold suspend device systems, control to range systems (CTRS), and control to target systems (CTTS).

Based on the geographical region, the global artificial pancreas device systems market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global market, with the increasing number of diabetes cases and growing awareness with the advancement in research and technology in the region. However, with the maximum increase in diabetes cases; India, China, Japan, Pakistan, the U.S., and Indonesia are expected to be potential markets for artificial pancreas device systems. Thus, Asia Pacific and North America are propelling the global market for artificial pancreas device systems. The market in Europe is also likely to witness growth with the increasing awareness in the region.

Some players operating in the global artificial pancreas device systems market are Medtronic, Johnson & Johnson, Beta Bionics, Pancreum, LLC, and JDRF. 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19370

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Digital Microscope Market - Global Industry Volume and Region Analysis - 2024

Digital microscope is an advanced microscope that has an LED screen instead of an eyepiece in a traditional compound microscope. The image can be directly seen on the monitor without an eyepiece. The magnification of the image depends on the lenses used in the microscope. The traditional microscope or compound microscope can be often aided with a camera and attached to a computer, having the software to capture the images of the objects. However, these microscopes cannot be categorized as digital microscope. The key advantage of digital microscope is that the image of an object can be viewed easily and immediately while in a comfortable position. And it can be discussed and shared with others. Digital microscope is of great help for people who work for longer periods on microscopes or if large number of samples need to be examined.

In terms of type, the digital microscope market can be segmented into desktop digital microscope, portable or pocket size digital microscope, and wireless digital microscope. Desktop digital microscopes are primarily used in life sciences research labs, textile industry for examining fiber quality, surface metrology, and also in forensics. Pocket size or portable digital microscopes can be carried easily and conveniently, and hence can be used in field work by environmental scientists, horticulturists to recognize insects and plant diseases, printers in the printing industry, and art restorers. Wireless digital microscopes enable sharing of captured images on many screens simultaneously.


Based on application, the digital microscope market can be segmented into scientific research, biomedicine, cosmetology, and industry. Scientific research employs considerable use of digital microscope. It is used in life sciences to study the cell and biomolecules, their functioning and microstructures. In forensic science, it is used to find and examine the trace evidences, DNA extraction from blood or hair, and finely examining the questioned documents, signatures, handwritings, etc. In material science, earth science and chemical science, digital microscope is used to study the fine structure of molecules and nano particles. Digital microscope plays a crucial role in biomedicine and pharmaceutical engineering. It is used by an audiologist to examine the inner ear carefully, and by the dentist for fine examination of teeth. Digital microscopy is of great help to the cosmetologist to closely examine the skin and hair and proceed further with the needful treatment. Industrial uses of digital microscopes are endless. It is used in microelectronics and semi-conductors; metallurgy, medical devices, watch making, jewelry making, metals and machines engineering, etc.

In terms of region, the digital microscope market can be segmented into North America (U.S. and Canada), Europe (Germany, France, U.K., Russia, and Italy), Asia Pacific (China, Japan, South Korea, India, and Southeast Asia), Latin America, and Middle East & Africa.

The digital microscope market is driven by high resolution digital camera, advanced printing techniques, and diversified microscopy techniques. However, the traditional microscope equipped with digital camera in place of eyepiece and computer also serves the purpose and is cost effective as compared to a digital microscope. Despite the versatility of digital microscope, combination of advanced digital technology and the basic features of microscopes makes them appropriate for research, education, and industry. Some digital microscopes have special features such as ability to tilt objects and view in three dimensions from different angles that enables them to outstrip traditional microscopes. The distinctive features of digital microscope such as ability to form digital still images and videos, easy documentation and sharing, makes the digital microscope proficient enough to dominate the market. Advancement of digital technology and electronics is likely to drive the digital microscope market in the near future.

Major players in the digital microscope market are Olympus Corporation, Celestron, Leica Microsystems, Motic, Carl Zeiss, Keyence Corporation, Jeol, Ltd., Hirox, and Nikon Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19004

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global OTC Orthopedic Braces Market Key Trends & Industry Forecast 2016 - 2024

Orthopedic braces are devices which are used to support and control the joints of the body. The braces can be used on the ankle, knee, hip, back, neck, elbow, fingers, and wrist. Orthopedic braces are used to control the position of limbs and initiate specific movement or motion in the body. Also, the braces can be compensated for weak muscles and to correct structural deformities.  Orthopedic braces are used extensively for diagnosis of cerebral palsy, spina bifida, spinal cord injury, scoliosis, and to deal with after stroke effects. Braces are also used after surgeries on knee joints in order to keep the joints immobile and control motion until the joints recover. Many people use braces for extra support to prevent injuries to joints. Athletes such as football and rugby players’ particularly use braces to prevent injuries. The sophisticated designs, cost effectiveness, and easy availability are driving the growth of the OTC orthopedic braces market. Custom braces and relevant designs can increase the cost of braces which may restrain the OTC orthopedic braces market growth rate during the forecast period. 


Orthotics is an example which is more than a shoe inserts. Orthotics manufacture and design orthoses which modifies the structure and function of the skeletal and neuromuscular system of the body. Demand for orthopedic braces has increased due to increase in the geriatric population, obesity, rising public participation in sports, orthopedic injuries among younger population, and rise in incidence of bone -degenerative diseases, all of which are driving growth in the OTC orthopedic braces market. According to the American Journal of Orthopedics, August 2016, osteoarthritis is a leading cause of disability among middle-aged and older adults, affecting nearly 27 million Americans. Increase in aging of the baby boomer population and rising obesity rates are estimated to increase osteoarthritis by 40% by 2025. Moreover, noninvasive nature of treatment using orthopedic braces and supports, reduced reimbursements offered during orthopedic surgery in developed regions such as North America and Europe are expected to propel the growth opportunities for sports players representing at a global, national or state level. High patient preference for alternative treatments, supports in prophylactic and rehabilitative use and lack of customization options for OTC orthopedic braces can hamper the growth of the global OTC orthopedic brace market during the forecast period. 

The OTC orthopedic braces market has been segmented by product type, indication, end-users, and geography. In terms of product type, the OTC orthopedic braces market is classified into foot & ankle braces, upper extremity braces, knee braces, and spinal orthoses braces. In terms of indication type, the market is classified into injury, arthritis, prophylactic, and others. According to the professor of Boston University School of Medicine, knee osteoarthritis is progressive damage to joint cartilage which leads to weakened muscles, pain and swelling. People who wore knee braces reduced pain by about 40% over 6 weeks. In terms of end users, the OTC orthopedic braces market is classified into orthopedic clinics, hospitals, pharmacies, and others. Geographically, the OTC orthopedic braces market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. 

Geographically North America dominates the global OTC orthopedic braces reagents market due to increase in obesity, increase in sports activity, and rise in aging  population. Reduced reimbursement policy for surgeries and low cost of braces is expected to drive the OTC orthopedic braces reagents market in North America. Europe is the second largest market for OTC orthopedic braces reagents as there are favorable government policies regarding healthcare infrastructure and awareness programs.  Asia Pacific is expected to grow at a higher rate due to rising population, changing lifestyles, rising interest in sports activity among the population, and increasing per capita expenditure. In addition, economic growth is supporting healthcare infrastructure improvement in developing countries such as Brazil, India, and China. Thus, all these factors collectively support the growth of the OTC orthopedic braces reagents market in Asia Pacific and Latin America. 

The major players operating in the global OTC orthopedic braces reagents market include ALCARE Co., Ltd., DJO Finance LLC, DeRoyal Industries Inc., Ossur hf., Breg, Inc., 3M Company, Otto Bock HealthCare, Bauerfeind AG, BSN Medical, medi GmbH & Co. KG, and Thuasne Group. 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19220

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.